Home/60 Degrees Pharmaceuticals/Geoffrey S. Dow

GS

Geoffrey S. Dow

Chief Executive Officer & Chairman

60 Degrees Pharmaceuticals

Therapeutic Areas

Infectious Disease Tropical Disease

60 Degrees Pharmaceuticals Pipeline

Drug	Indication	Phase
ARAKODA® (Tafenoquine)	Malaria Prophylaxis	Approved
Tafenoquine	P. vivax Malaria Radical Cure	Phase 3

Leadership Team at 60 Degrees Pharmaceuticals

Chief Regulatory Affairs Officer

View full 60 Degrees Pharmaceuticals profile